APP and amyloidosis: APP/PS1 mice treated with intraperitoneal memantine injections of 10 mg/kg for 4 months also revealed significantly reduced amyloid plaque burden in cortex and hippocampus at the age of 7 months, together with significant improvements in a novel object recognition task test of short-term memory [14].